A groundbreaking wearable device, Diadem, is set to revolutionize the treatment of chronic pain, offering rapid and sustained relief in as little as one 40-minute session. This innovative technology has the potential to transform the lives of the estimated 20% to 30% of people worldwide who suffer from chronic pain conditions such as fibromyalgia, back pain, and neuropathy.
The Diadem device works by noninvasively stimulating deep brain regions involved in pain processing, potentially disrupting faulty pain signals. Unlike current treatments like medication and surgery, which often have limited effectiveness and significant side effects, Diadem has shown promising results in clinical trials.
In a recent study, 60% of participants experienced a clinically meaningful reduction in pain symptoms just one day after a single treatment session, with the effects lasting for at least a week. The device was well-tolerated, with no adverse events detected, as reported by the University of Utah. The findings are published in PAIN.
“We’ve been blown away by the positive results so far,” the paper’s lead author, Tom Riis, a postdoctoral researcher in the Department of Biomedical Engineering said as reported by New Atlas. “After just a single 40-minute stimulation session, patients are showing immediate, clinically substantial improvements in symptoms.”
As researchers prepare for a Phase 3 clinical trial, the final step before FDA approval, there is hope that Diadem could become widely available to the millions of people struggling with chronic pain. This innovative treatment also has the potential to help address the opioid crisis by reducing the need for addictive pain medications.
If you or a loved one suffers from chronic pain, keep an eye out for updates on the Diadem clinical trial and talk to your healthcare provider about potential participation. This wearable device may just be the breakthrough you’ve been waiting for.
